Rakuten Securities Inc. purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 5,590 shares of the company’s stock, valued at approximately $2,700,000. Astera Labs comprises 0.6% of Rakuten Securities Inc.’s holdings, making the stock its 26th biggest holding.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in Astera Labs in the 2nd quarter valued at about $6,609,581,000. Atreides Management LP lifted its position in shares of Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after purchasing an additional 1,754,593 shares in the last quarter. Amundi grew its stake in shares of Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after purchasing an additional 1,319,643 shares during the last quarter. Artisan Partners Limited Partnership bought a new stake in shares of Astera Labs during the fourth quarter valued at approximately $148,980,000. Finally, Goldman Sachs Group Inc. grew its stake in shares of Astera Labs by 189.0% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock valued at $218,419,000 after purchasing an additional 858,693 shares during the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.
Astera Labs Trading Down 1.9%
NASDAQ ALAB opened at $284.97 on Friday. The stock has a 50-day simple moving average of $352.70 and a 200 day simple moving average of $244.92. The company has a market capitalization of $49.44 billion, a PE ratio of 141.07 and a beta of 3.84. Astera Labs, Inc. has a 12 month low of $97.89 and a 12 month high of $499.48.
Insiders Place Their Bets
In related news, CEO Jitendra Mohan sold 90,630 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the transaction, the chief executive officer owned 1,266,665 shares in the company, valued at approximately $431,109,432.75. The trade was a 6.68% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the company’s stock in a transaction that occurred on Thursday, August 6th. The shares were sold at an average price of $311.83, for a total transaction of $2,804,599.02. Following the completion of the sale, the director directly owned 3,970 shares of the company’s stock, valued at $1,237,965.10. The trade was a 69.38% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 419,244 shares of company stock worth $163,135,169 over the last ninety days. Company insiders own 10.40% of the company’s stock.
Wall Street Analyst Weigh In
ALAB has been the subject of several research analyst reports. Weiss Ratings restated a “hold (c)” rating on shares of Astera Labs in a research report on Tuesday. Jefferies Financial Group increased their price objective on Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. Northland Securities raised Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 target price for the company in a research note on Monday, August 17th. Evercore restated an “outperform” rating and set a $297.00 target price on shares of Astera Labs in a research report on Tuesday, May 19th. Finally, Zacks Research raised Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and an average price target of $333.00.
View Our Latest Report on Astera Labs
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Further Reading
- Five stocks we like better than Astera Labs
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
